Clinical Trial Update: Trial to Assess Chelation Therapy (TACT) [Phase 3]

View source ↗

Summary

Phase 3 Trial to Assess Chelation Therapy (TACT) for coronary artery disease has completed and posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• EDTA chelation therapy (edetate disodium)

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-11-05